GlassScriptPhysician profile
Wesley Lloyd Robinson
NPI 1508066580
$4,917.29
in general payments reported to CMS, 2019-2025
9 companies · $84.66 in 2025
The $84.66 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $361 · 2021: $542 · 2023: $345 · 2024: $2,705 · 2025: $84.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,892 · Food and Beverage: $875 · Gift: $268 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,891.50 |
| Food and Beverage | $875.09 |
| Gift | $268.37 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,835.76 | 2020-2025 | Invisalign, Invisalign First - Comprehensive, Invisalign Touch Up |
| American Orthodontics Corporation | $981.95 | 2019-2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Envista Holdings Corporation | $420.45 | 2024 | Damon, Insignia, Spark |
| Ultradent Products INC | $304.98 | 2021 | |
| Ormco Corporation | $251.87 | 2020-2023 | Spark |
| Nobel Biocare USA | $79.92 | 2023 | Nobelactive |
| Solventum Corporation | $14.45 | 2025 | 3m |
| Ortho Organizers, INC. | $14.41 | 2020 | |
| Dentsply Sirona INC | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.